Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer

Nur Mohammad Monsur Hassan, Mitsuhiro Tada, Jun ichi Hamada, Haruhiko Kashiwazaki, Takeshi Kameyama, Rahena Akhter, Yutaka Yamazaki, Masahiro Yano, Nobuo Inoue, Tetsuya Moriuchi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Genetic alteration of p53 is a significant determining factor in the carcinogenesis. The loss of function, mutant p53 can possess a dominant negative effect on wild-type p53 and may also exert gain-of-function activity. It is, however, not clear how p53 functional status due to various types of mutation results in outcome of patients with oral cancer. A total of 60 oral SCC samples were subjected to yeast functional assay that screens human p53 function in yeast, and sequencing for determination of p53 mutations. The detected mutants were further investigated for their dominant negative activity using a yeast-based transdominance assay that tests dominant negative activity of a mutant p53 over wild-type p53 by coexpressing the mutant and wild-type p53 in a yeast transcriptional reporter system. p53 mutation was found in 42 out of 60 of which 10 (24%) exhibited dominant negative activity and 32 (76%) without dominant activity (recessive mutation). The remaining 18 (30%) were considered to have wild-type p53. The patients with dominant negative mutation had significantly shorter disease-free survival than patients with no mutation (log-rank test, p < 0.001) and those with a recessive mutation (p < 0.016). There were slight significant differences in disease-free survival were found between the patients with tumours harbouring a recessive p53 mutation and those with tumours harbouring a wild-type p53 (p < 0.038). The presence and absence of a dominant negative p53 mutation may thus provide a predictor of early recurrence in oral SCC patients.

Original languageEnglish
Pages (from-to)108-119
Number of pages12
JournalCancer Letters
Volume270
Issue number1
DOIs
Publication statusPublished - Oct 18 2008

Fingerprint

Mouth Neoplasms
Recurrence
Mutation
Yeasts
Disease-Free Survival
Neoplasms
Carcinogenesis

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Hassan, N. M. M., Tada, M., Hamada, J. I., Kashiwazaki, H., Kameyama, T., Akhter, R., ... Moriuchi, T. (2008). Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer. Cancer Letters, 270(1), 108-119. https://doi.org/10.1016/j.canlet.2008.04.052

Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer. / Hassan, Nur Mohammad Monsur; Tada, Mitsuhiro; Hamada, Jun ichi; Kashiwazaki, Haruhiko; Kameyama, Takeshi; Akhter, Rahena; Yamazaki, Yutaka; Yano, Masahiro; Inoue, Nobuo; Moriuchi, Tetsuya.

In: Cancer Letters, Vol. 270, No. 1, 18.10.2008, p. 108-119.

Research output: Contribution to journalArticle

Hassan, NMM, Tada, M, Hamada, JI, Kashiwazaki, H, Kameyama, T, Akhter, R, Yamazaki, Y, Yano, M, Inoue, N & Moriuchi, T 2008, 'Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer', Cancer Letters, vol. 270, no. 1, pp. 108-119. https://doi.org/10.1016/j.canlet.2008.04.052
Hassan, Nur Mohammad Monsur ; Tada, Mitsuhiro ; Hamada, Jun ichi ; Kashiwazaki, Haruhiko ; Kameyama, Takeshi ; Akhter, Rahena ; Yamazaki, Yutaka ; Yano, Masahiro ; Inoue, Nobuo ; Moriuchi, Tetsuya. / Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer. In: Cancer Letters. 2008 ; Vol. 270, No. 1. pp. 108-119.
@article{ee10907f5b2f42298c8a9764ef78cbef,
title = "Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer",
abstract = "Genetic alteration of p53 is a significant determining factor in the carcinogenesis. The loss of function, mutant p53 can possess a dominant negative effect on wild-type p53 and may also exert gain-of-function activity. It is, however, not clear how p53 functional status due to various types of mutation results in outcome of patients with oral cancer. A total of 60 oral SCC samples were subjected to yeast functional assay that screens human p53 function in yeast, and sequencing for determination of p53 mutations. The detected mutants were further investigated for their dominant negative activity using a yeast-based transdominance assay that tests dominant negative activity of a mutant p53 over wild-type p53 by coexpressing the mutant and wild-type p53 in a yeast transcriptional reporter system. p53 mutation was found in 42 out of 60 of which 10 (24{\%}) exhibited dominant negative activity and 32 (76{\%}) without dominant activity (recessive mutation). The remaining 18 (30{\%}) were considered to have wild-type p53. The patients with dominant negative mutation had significantly shorter disease-free survival than patients with no mutation (log-rank test, p < 0.001) and those with a recessive mutation (p < 0.016). There were slight significant differences in disease-free survival were found between the patients with tumours harbouring a recessive p53 mutation and those with tumours harbouring a wild-type p53 (p < 0.038). The presence and absence of a dominant negative p53 mutation may thus provide a predictor of early recurrence in oral SCC patients.",
author = "Hassan, {Nur Mohammad Monsur} and Mitsuhiro Tada and Hamada, {Jun ichi} and Haruhiko Kashiwazaki and Takeshi Kameyama and Rahena Akhter and Yutaka Yamazaki and Masahiro Yano and Nobuo Inoue and Tetsuya Moriuchi",
year = "2008",
month = "10",
day = "18",
doi = "10.1016/j.canlet.2008.04.052",
language = "English",
volume = "270",
pages = "108--119",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer

AU - Hassan, Nur Mohammad Monsur

AU - Tada, Mitsuhiro

AU - Hamada, Jun ichi

AU - Kashiwazaki, Haruhiko

AU - Kameyama, Takeshi

AU - Akhter, Rahena

AU - Yamazaki, Yutaka

AU - Yano, Masahiro

AU - Inoue, Nobuo

AU - Moriuchi, Tetsuya

PY - 2008/10/18

Y1 - 2008/10/18

N2 - Genetic alteration of p53 is a significant determining factor in the carcinogenesis. The loss of function, mutant p53 can possess a dominant negative effect on wild-type p53 and may also exert gain-of-function activity. It is, however, not clear how p53 functional status due to various types of mutation results in outcome of patients with oral cancer. A total of 60 oral SCC samples were subjected to yeast functional assay that screens human p53 function in yeast, and sequencing for determination of p53 mutations. The detected mutants were further investigated for their dominant negative activity using a yeast-based transdominance assay that tests dominant negative activity of a mutant p53 over wild-type p53 by coexpressing the mutant and wild-type p53 in a yeast transcriptional reporter system. p53 mutation was found in 42 out of 60 of which 10 (24%) exhibited dominant negative activity and 32 (76%) without dominant activity (recessive mutation). The remaining 18 (30%) were considered to have wild-type p53. The patients with dominant negative mutation had significantly shorter disease-free survival than patients with no mutation (log-rank test, p < 0.001) and those with a recessive mutation (p < 0.016). There were slight significant differences in disease-free survival were found between the patients with tumours harbouring a recessive p53 mutation and those with tumours harbouring a wild-type p53 (p < 0.038). The presence and absence of a dominant negative p53 mutation may thus provide a predictor of early recurrence in oral SCC patients.

AB - Genetic alteration of p53 is a significant determining factor in the carcinogenesis. The loss of function, mutant p53 can possess a dominant negative effect on wild-type p53 and may also exert gain-of-function activity. It is, however, not clear how p53 functional status due to various types of mutation results in outcome of patients with oral cancer. A total of 60 oral SCC samples were subjected to yeast functional assay that screens human p53 function in yeast, and sequencing for determination of p53 mutations. The detected mutants were further investigated for their dominant negative activity using a yeast-based transdominance assay that tests dominant negative activity of a mutant p53 over wild-type p53 by coexpressing the mutant and wild-type p53 in a yeast transcriptional reporter system. p53 mutation was found in 42 out of 60 of which 10 (24%) exhibited dominant negative activity and 32 (76%) without dominant activity (recessive mutation). The remaining 18 (30%) were considered to have wild-type p53. The patients with dominant negative mutation had significantly shorter disease-free survival than patients with no mutation (log-rank test, p < 0.001) and those with a recessive mutation (p < 0.016). There were slight significant differences in disease-free survival were found between the patients with tumours harbouring a recessive p53 mutation and those with tumours harbouring a wild-type p53 (p < 0.038). The presence and absence of a dominant negative p53 mutation may thus provide a predictor of early recurrence in oral SCC patients.

UR - http://www.scopus.com/inward/record.url?scp=50649125210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50649125210&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2008.04.052

DO - 10.1016/j.canlet.2008.04.052

M3 - Article

C2 - 18555592

AN - SCOPUS:50649125210

VL - 270

SP - 108

EP - 119

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -